Print this page
March 28, 2014

University of Alabama at Birmingham receives $35 million for infectious disease research

Written by
The University of Alabama at Birmingham has been awarded $35 million from the National Institute of Allergy and Infectious Diseases to establish a research center focused on developing new drug therapies for global infectious disease threats such as influenza, West Nile and Middle East respiratory syndrome, or MERS, coronavirus.